Riskpilot← Back to searchSign inGet full accessMZA INVEST AS
ASActiveOrg 914852099Slettheimveien 11A, 2007 KjellerGeneral medical practice activities · NACE 8621Est. 20150 employees
Revenue 2024
NOK 154K
EBITDA margin
54.1%
+525% vs 2023
Equity ratio
42.9%
Financial strength
Net profit 2024
NOK 1,8M
-2% vs 2023
| Revenue | NOK 154K | — |
| EBITDA | NOK 83K | +525% |
| Net profit | NOK 1,8M | -2% |
| Total assets | NOK 12,2M | +121% |
| Equity | NOK 5,2M | +52% |
| Employees | 0 | — |
Legal name
MZA INVEST AS
Org number
914852099
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
23. januar 2015
Share capital
NOK 40 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Slettheimveien 11A, 2007 Kjeller
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 154 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −12 | −8 | −23 | −20 | 83 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −148 |
| EBIT | −12 | −8 | −23 | −20 | −65 |
| Net financials | 1 000 | 900 | 1 138 | 1 840 | 1 853 |
| Profit before tax | 988 | 892 | 1 115 | 1 820 | 1 789 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 988 | 892 | 1 115 | 1 820 | 1 789 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 186 | 1 515 | 4 638 | 5 517 | 12 182 |
| Equity | 1 044 | 1 507 | 2 402 | 3 442 | 5 231 |
| Long-term debt | 126 | 0 | 1 647 | 1 576 | 6 478 |
| Short-term debt | 15 | 8 | 590 | 499 | 473 |
| Total debt | 141 | 8 | 2 237 | 2 075 | 6 951 |
EBITDA margin
54.1%
This company
15.8%
Market median
+242% vs market
20202024
Equity ratio
42.9%
This company
38.2%
Market median
+12% vs market
20202024
Return on equity
34.2%
This company
18.4%
Market median
+86% vs market
20202024
Net profit margin
1161.4%
This company
8.1%
Market median
+14238% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MZ Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MZA INVEST AS (this company)
AVICENNA KLINIKK ASBoard members of MZA INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammad Zaheer Abbas | Chief Executive Officer | 0 companies |